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Glucose stimulates somatostatin secretion in
pancreatic δ-cells by cAMP-dependent intracellular
Ca2+ release
Geoffrey Denwood1*, Andrei Tarasov1,5*, Albert Salehi2, Elisa Vergari1, Reshma Ramracheya1, Harumi Takahashi3, Viacheslav O. Nikolaev6,
Susumo Seino3, Fiona Gribble4, Frank Reimann4, Patrik Rorsman1,2, and Quan Zhang1
Somatostatin secretion from pancreatic islet δ-cells is stimulated by elevated glucose levels, but the underlying mechanisms
have only partially been elucidated. Here we show that glucose-induced somatostatin secretion (GISS) involves both membrane
potential-dependent and -independent pathways. Although glucose-induced electrical activity triggers somatostatin release,
the sugar also stimulates GISS via a cAMP-dependent stimulation of CICR and exocytosis of somatostatin. The latter effect is
more quantitatively important and in mouse islets depolarized by 70 mM extracellular K+, increasing glucose from 1 mM to
20 mM produced an ∼3.5-fold stimulation of somatostatin secretion, an effect that was mimicked by the application of the
adenylyl cyclase activator forskolin. Inhibiting cAMP-dependent pathways with PKI or ESI-05, which inhibit PKA and exchange
protein directly activated by cAMP 2 (Epac2), respectively, reduced glucose/forskolin-induced somatostatin secretion.
Ryanodine produced a similar effect that was not additive to that of the PKA or Epac2 inhibitors. Intracellular application of
cAMP produced a concentration-dependent stimulation of somatostatin exocytosis and elevation of cytoplasmic Ca2+ ([Ca2+]i).
Both effects were inhibited by ESI-05 and thapsigargin (an inhibitor of SERCA). By contrast, inhibition of PKA suppressed δ-cell
exocytosis without affecting [Ca2+]i. Simultaneous recordings of electrical activity and [Ca2+]i in δ-cells expressing the
genetically encoded Ca2+ indicator GCaMP3 revealed that the majority of glucose-induced [Ca2+]i spikes did not correlate with
δ-cell electrical activity but instead reflected Ca2+ release from the ER. These spontaneous [Ca2+]i spikes are resistant to PKI but
sensitive to ESI-05 or thapsigargin. We propose that cAMP links an increase in plasma glucose to stimulation of somatostatin
secretion by promoting CICR, thus evoking exocytosis of somatostatin-containing secretory vesicles in the δ-cell.
Introduction
Pancreatic islets play a central role in metabolic homeostasis by
secreting insulin and glucagon, the body’s two principal glu-
coregulatory hormones. Insulin, released from pancreatic β-cells
in response to elevated plasma glucose, is the only hormone
capable of lowering blood glucose (Rorsman and Renstro¨m,
2003). Glucagon, released by the pancreatic α-cells in response
to hypoglycemia and adrenaline, is the principal plasma
glucose–increasing hormone (Gylfe and Gilon, 2014; Rorsman
et al., 2014). Somatostatin, secreted by pancreatic δ-cells when
glucose is elevated (Hauge-Evans et al., 2009), is a powerful
paracrine inhibitor of both insulin and glucagon secretion
(Cejvan et al., 2003; Hauge-Evans et al., 2009; Cheng-Xue et al.,
2013), and there is circumstantial evidence that aberrant
somatostatin secretion contributes to the hormone secretion
defects associated with diabetes (Yue et al., 2012; Li et al., 2017).
However, the cellular regulation of somatostatin secretion re-
mains poorly understood. This is because δ-cells comprise only
5% of the islet cells (Brissova et al., 2005), making them difficult
to isolate and study.
We previously proposed that CICR accounts for ∼80% of
glucose-induced somatostatin secretion (GISS) and is triggered
by Ca2+ influx through R-type Ca2+ channels during electrical
activity, which activates RYR3 Ca2+-releasing channels (Zhang
et al., 2007). Interestingly, membrane depolarization per se was
found to be a weak stimulus of somatostatin secretion in the
absence of glucose, indicating that glucose somehow regulates
CICR. However, the identity of the intracellular coregulator of
CICR is unknown. Here we propose that cAMP represents this
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elusive intracellular regulator, and we have dissected the major
cAMP-dependent molecular signaling pathways in the regula-
tion of somatostatin secretion.
Materials and methods
Animals and isolation of pancreatic islets
All animal experiments were conducted in accordance with the
UK Animals Scientific Procedures Act (1986) and the University
of Oxford ethical guidelines. Mice were killed by a Schedule
1 procedure (cervical dislocation) and the pancreases quickly
resected following intraductal injection with 0.1 mg/ml liberase
(TL research grade; Roche) dissolved in Hank’s buffer (Sigma-
Aldrich). Islets were then isolated by liberase digestion at 37°C
before being hand picked and placed into culture medium
(RPMI-1640; Gibco). The secretion studies and most of the
electrophysiology experiments were performed on islets isolated
from NMRI mice (Charles River Laboratories). A subset of the
electrophysiology and Ca2+ imaging experiments were per-
formed on islets from mice expressing a Cre reporter from the
Rosa26 locus, either the fluorescent protein tdRFP or the ge-
netically encoded Ca2+ indicator GCaMP3, conditionally activated
by iCre recombinase expressed under the control of the soma-
tostatin (SST) promoter (Chera et al., 2014; Zhang et al., 2014b;
Adriaenssens et al., 2016). These mice are referred to as SST-
tdRFP and SST-GCaMP3 in the text, respectively, and were bred
as reported previously (Adriaenssens et al., 2015). Mice lacking
exchange protein directly activated by cAMP 2 (Epac2−/−) were
generated as described elsewhere (Shibasaki et al., 2007).
Electrophysiology and capacitance measurements
of exocytosis
All electrophysiological measurements were performed using an
EPC-10 patch clamp amplifier and Pulse software (version 8.80;
HEKA Electronics). Electrical activity, membrane currents, and
changes in cell capacitance (reflecting exocytosis) were recorded
from superficial δ-cells in intact, freshly isolated mouse pan-
creatic islets (Go¨pel et al., 1999, 2004) using the perforated patch
or standard whole-cell techniques as indicated in the text and/or
figure legends. The δ-cells were first identified by immunocy-
tochemistry (Zhang et al., 2007), subsequently by electrophys-
iological fingerprinting (Briant et al., 2017), and most recently
via expression of fluorescent reporters under the control of the
somatostatin promoter as delineated above.
For experiments that required cells to be metabolically intact
(recordings in Fig. 1, A and D; Fig. 6, A and B; Fig. 7 E; Fig. 9, C
and D; Fig. 12; Fig. 13; and Fig. 14), the perforated patch technique
was used. The pipette solution contained (in mM) 76 K2SO4, 10
NaCl, 10 KCl, 1 MgCl2, and 5 HEPES (pH 7.35 with KOH).
Membrane perforation was achieved by inclusion of ampho-
tericin B (0.24mg/ml) or gramicidin D (20 µg/ml) in the pipette-
filling solution. The extracellular solution consisted of (in mM)
140 NaCl, 3.6 KCl, 0.5 MgSO4, 1.5 CaCl2, 0.5 NaH2PO4, 5 NaHCO3,
and 10 HEPES (pH 7.4 with NaOH). Glucose, mannoheptulose
(Sigma-Aldrich), depolarizing concentration of K+, tolbutamide,
and forskolin were included in the extracellular solutions at the
indicated concentrations.
Electrophysiological properties were almost identical in
δ-cells of wild-type animals (n = 6 from five animals) and δ-cells
expressing fluorescent reporters (tdRFP or GCaMP3, n = 3 from
three animals and n = 4 from four animals, respectively; Table 1).
Therefore, data from δ-cells identified by the different methods
were pooled (n = 13) for statistical analysis.
Exocytosis was detected as changes in cell capacitance, which
were estimated by the Lindau-Neher technique implementing
the “Sine+DC” feature of the lock-in module of the Pulse soft-
ware. The amplitude of the sine wave was 20 mV, and the fre-
quency was 1,250 Hz (Kanno et al., 2004). The pipette solution
dialyzing the cell interior contained (in mM) 125 Cs-glutamate,
10 CsCl, 10 NaCl, 1 MgCl2, 0.05 EGTA (or indo-1 for thein-
tracellular free Ca2+ concentration {[Ca2+]i} measurements),
3 Mg-ATP, and 5 HEPES (pH 7.1 using CsOH). cAMP, myr-
istoylated PKI 14–22 amide (PKI, a PKA inhibitor; Tocris), and
ESI-05 (4-methylphenyl-2,4,6-trimethylphenysulfone, an Epac-
2 inhibitor, BioLog) were included in the intracellular (pipette-
filling) solutions as indicated. For the capacitance measurements
with Ca2+ infusion (Fig. 9, A and B), the pipette solution con-
tained (in mM) 110 Cs-glutamate, 10 KCl, 10 NaCl, 1 MgCl2, 3
MgATP, 5 HEPES, and 10 EGTA with either 3 or 5 CaCl2 to
achieve the free [Ca2+]i of 103 nM or 240 nM, respectively (pH
7.15 with CsOH). After establishment of the whole-cell config-
uration, a 5-min wash-in period was allowed to “clamp” the
[Ca2+]i in cells that were voltage-clamped at −70 mV before
commencing the electrical stimulation. The standard extracel-
lular medium used for the capacitance measurements consisted
of (in mM) 118 NaCl, 20 tetraethylammonium-Cl (to block out-
ward K+-currents), 5.6 KCl, 1.2 MgCl2, 5 HEPES, 2.6 CaCl2, and
1 D-glucose (pH 7.4 with NaOH).
For unknown reasons, the δ-cell exocytotic response to a
500-ms depolarization to 0 mV in the presence of cAMP was
50% lower in islets from SST-tdRFP mice (87 ± 21 fF, n = 16 cells
from seven animals) than in islets from NMRI mice (187 ± 22 fF,
n = 15 cells from 12 animals; P < 0.05). For this reason, the
analyses in Figs. 6, 7, 8, 9, 10, and 11 are restricted to δ-cells
identified by immunocytochemistry after the electrophysiolog-
ical measurements.
Patch pipettes were pulled from borosilicate glass with re-
sistances of ∼5 MΩ when filled with the pipette solutions.
Standard whole-cell configuration was achieved by rupturing
the cell membrane included in the patching electrode (with se-
ries resistance of <30 MΩ). All electrophysiological measure-
ments were performed at 32–34°C.
[Ca2+]i measurements and imaging
For data in Fig. 7, A–D; Fig. 8; Fig. 10; and Fig. 11 A, [Ca2+]i was
monitored using the ratiometric indicator indo-1 and a Photon
Technology International RM-2/2005 fluorescence micro-
fluorimetry system mounted on a Nikon E600FN upright mi-
croscope. The fluorophore was excited at 360 nm and the
emitted light, after being split by a dichroic mirror, was detected
by two parallel photomultipliers at 405 and 485 nm, res-
pectively. The standard whole-cell configuration was used,
with EGTA equimolarly replaced by indo-1. During these ex-
periments, the islets were exposed to 1 mM glucose. Signal
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processing was performed online using Felix software (version
1.2; Photon Technology International). The background signal
was measured at each wavelength before establishment of the
whole-cell configuration and subtracted from the experimental
values. The system was calibrated by using a series of intracel-
lular solutions containing different concentrations of Ca2+ (ob-
tained by mixing different concentrations of CaCl2 and EGTA).
The values of Rmin (fluorescence ratio in the absence of Ca2+,
1.35), Rmax (fluorescence ratio at saturating [Ca2+]i, 5.03), and Kd
(178.5) thus derived were fed into the Felix software to convert
the measured F405/F485 ratio to the [Ca2+]i. Baseline correction,
data analysis, and presentation were performed using Clampfit
(version 9.2.0.11; Molecular Devices).
For data in Fig. 5, [Ca2+]i dynamics was measured by changes
in fluorescence of GCaMP3 (ΔF/Fo, fluorescence intensity nor-
malized to basal) specifically expressed in δ-cells (from SST-
GCaMP3 mice). The experiments were conducted using an
upright Zeiss Axioskop 2FS microscope equipped with the Zeiss
510-META laser scanning system. GCaMP3 was excited by a
488-nm laser and emitted light was collected at 510 nm. Images
were taken every 3 s using the ZenBlue software (Carl Zeiss).
Data were analyzed using Fiji imaging processing package (Na-
tional Institutes of Health).
For data in Fig. 7 E, Fig. 9, C and D, Fig. 12, Fig. 13, and Fig. 14,
[Ca2+]i dynamics were also reported by changes in fluorescence
of GCaMP3 (ΔF/Fo) in δ-cells from SST-GCaMP3 mice. The ex-
perimental settings were identical to the ones used for indo-
1 measurement, but GCaMP3 was excited at 480 nm using a
light-emitting diode source (wLS LED Illumination Unit; QI-
maging). The emitted light passed through a FITC filter set (di-
chromic mirror 505 and barrier filter 535/45; Nikon, Japan) and
was captured by a scientific Complementary Metal-Oxide-
Semiconductors (CMOS) camera (OptiMOS, QImaging). To as-
certain that [Ca2+]i and electrical activity were recorded from
the same cell, a 500-ms voltage-clamp depolarization from
−70 mV to 0 mVwas applied first to elicit a transient increase in
GCaMP3 fluorescence. The time-lapse image series were re-
corded using the Micro-Manager software (Ron Vale laboratory,
University of California, San Francisco) at a frequency of 1 Hz.
Synchronization of imaging acquisition and electrophysiology
recordings was achieved by a TTL (Transistor-Transistor Logic)
trigger signal produced by the sCMOS camera. Imaging data
were analyzed using the Fiji image processing package, and
baseline correction was performed using Clampfit.
The inositol triphosphate (InsP3) uncaging experiments
(Fig. 6, C–F) were performed using a BioRad Radiance 2100
scanning laser confocal system mounted on a Nikon Eclipse
E600FN upright microscope. The recordings were performed
using standard whole-cell configuration (series resistance < 30
MΩ) with the pipette solutions supplementedwith 25 µM Fluo-4
(Thermo Fisher Scientific) and 50 µM caged InsP3 precursor
(Calbiochem). Liberation of InsP3 was achieved by delivering a
pulse of UV light flash (JML-C2; Rapp OptoElectronic). [Ca2+]i
was monitored as changes in intensity of Fluo-4 fluorescence
(ΔF). Fluo-4 was excited by a 488-nm laser with emitted light
collected at 510-nm wavelength. Simultaneously with the
measurements of [Ca2+]i, cell exocytosis was monitored as in-
creases in cell capacitance (ΔCm) by the Pulse software.
All [Ca2+]i measurement/imaging experiments were con-
ducted at 32–34°C.
Somatostatin release
Somatostatin secretion was measured in static incubations
essentially as previously described (Zhang et al., 2007; Braun
et al., 2009). Briefly, freshly isolated islets were preincubated
for 30 min at 37°C in Krebs–Ringer buffer consisting of (in
mM) 140 NaCl, 3.6 KCl, 0.5 MgSO4, 2.6 CaCl2, 0.5 NaH2PO4,
2 NaHCO3, 1 glucose, and 5 HEPES (pH 7.4 with NaOH). For
secretion triggered by supraphysiological concentration of
extracellular K+ ([K+]o; data in Fig. 1 C and Fig. 4), the KCl
concentration was increased to 70 mM (the NaCl concentra-
tion was correspondingly reduced to maintain iso-osmolality;
∼300 milliosmoles/l). For glucose-stimulated somatostatin
secretion, 10 mM or 20 mM glucose was included in the
testing buffer. A previous study (Walker et al., 2011) indicated
that the two concentrations stimulate somatostatin secretion
to a similar extent. Groups of 10–20 islets were then incubated
for 60 min at 37°C in 1 ml of solution supplemented as indi-
cated in the figure legends. Immediately after incubation, an
aliquot of the medium was removed for determination of so-
matostatin concentration using a commercial radioimmuno-
assay (Diasource).
Table 1. Electrical activity of δ-cells measured in islets from different mouse models
1 mM glucose 10 mM glucose 0.2 mM tolbutamide
Vm (mV) Vpeak (mV) Frequency (Hz) Vm (mV) Vpeak (mV) Frequency (Hz) Vm (mV) Vpeak (mV) Frequency (Hz)
NMRI (n = 6) −71 ± 3 n/a n/a −54 ± 3a 6 ± 4 0.6 ± 0.2 −48 ± 3b 4 ± 3b 0.6 ± 0.1
SST-tdRFP (n = 3) −74 ± 4 n/a n/a −62 ± 2a 14 ± 8 0.2 ± 0.2 −54 ± 3b 3 ± 3b 0.3 ± 02
SST-GCaMP3 (n = 4) −73 ± 3 n/a n/a −54 ± 3a 25 ± 8 0.6 ± 0.3 −37 ± 2b 8 ± 4b 0.4 ± 0.3
Electrical activity recorded from δ-cells in intact islets isolated from NMRI, SST-tdRFP, and SST-GCaMP3 mice. Membrane potential (Vm), Vpeak, and firing
frequency of action potentials when δ-cells were exposed to 1 mM glucose, 10 mM glucose, or 200 µM tolbutamide are summarized and compared between
different mouse strains. Data are presented as mean values ± SEM of indicated number of independent experiments (n) from three to five animals. No action
potential was detected at 1 mM glucose in all groups. Therefore the data for Vpeak and Frequency at 1 mM glucose are shown as n/a (not available). There were
no statistical differences between the different mouse models. All the measurements were made using perforated patch clamping technique.
aP < 0.05 vs. 1 mM glucose (for each model).
bP < 0.05 vs. 20 mM glucose (for each model).
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Measurements of islet cAMP content
Freshly isolated islets were preincubated for 2 h at 37°C in
RPMI containing no glucose and supplemented with 0.05%
BSA. The supernatant was discarded, and the islets were in-
cubated at 37°C for 30 min in 1 ml of Krebs–Ringer buffer
solution containing 0.05% BSA, 1 mM glucose, and 100 µM
isobutyl methylxanthine, supplemented with tolbutamide
(200 µM). Islets were also incubated in the presence of 1 or
10 mM glucose (no tolbutamide but with isobutyl methyl-
xanthine). cAMP was extracted by adding 400 µl of ice-cold
Na+-acetate buffer (50 mM, pH 6.2) to the islets. The pelleted
samples were boiled for 10 min and sonicated on ice before
being stored at −80°C. cAMP levels were determined using a
commercial radioimmunoassay (Amersham Pharmacia Bio-
tech). Aliquots of the supernatant were removed from the
same experiments for somatostatin measurements.
Measurements of cytoplasmic cAMP levels
The effects of forskolin and glucose on cytoplasmic cAMP
levels ([cAMP]i) in pancreatic islet cells were studied using a
recombinant FRET sensor Epac2-camps (Nikolaev et al.,
2004). Islets isolated from SST-tdRFP mice were dispersed
into single-cell suspension before being plated on glass
coverslips. Epac2-camps was delivered via adenoviral in-
fection (104 units per cell). The imaging experiments were
performed 36–48 h after infection using a Zeiss Axioskop 2FS
microscope equipped with a 40×/1.3 objective, a Lambda DG-
4 exciter (Sutter Instruments) and an Orca-R2 cooled CCD
camera (Hamamatsu). The CFP fluorescence was excited at
436 nm, and the emitted light was collected at 485 nm and
535 nm using a Dual-view beam splitter (Photometrics). The
images were acquired at 37°C using the Micro-Manager
software (Ron Vale laboratory, University of California,
San Francisco) and normalized to the initial fluorescence
(F/F0), after which the CFP/YFP ratio was calculated using
ImageJ (Wayne Rasband, National Institutes of Health). Data
analysis and representation were performed in Igor Pro
(Wavemetrics).
Immunocytochemistry
In some experiments, the identity of the δ-cells was established
by immunocytochemistry as previously described (Zhang et al.,
2007, 2014b). Briefly, biocytin (0.5 mg/ml) was injected into the
cells during the electrophysiology experiments via the patch
pipettes. The cell type (β-, α-, or δ-cell) was established using
antibodies directed against insulin, glucagon, and somatostatin,
and the biocytin-loaded cells were labeled by Alexa Fluor 543–
conjugated streptavidin.
Data analysis
The ΔCm was measured once a steady-state level had been at-
tained. Experimental data in Fig. 6, Fig. 7, Fig. 10, and Fig. 11 B
were approximated using a kinetic model, which considers the
transition of granules from the immediately releasable pool of
granules (IRP, abbreviated P in the equation) and a fused state.














where t is the time after onset of depolarization, α0 is the rate
constant of exocytosis from the IRP, and τ represents the time
constant for rapid granule release. Solutions to Eq. 1 were ap-
proximated from the experimental data to derive the initial
values of P, corresponding to the maximal size of the IRP of
granules. A full account of the Eq. 1 derivation has been reported
previously (Barg et al., 2001).
For data in Fig. 12, time-dependent changes of electrical ac-
tivity/action potential firing and [Ca2+]i were detected using
Clampfit, with a 20% detection threshold for both data channels
and analyzed using IgorPro (Wavemetrics). Idealized traces
were constructed using the peak timing of action potentials. The
idealized membrane potential trace was then convolved with an
exponential kernel (τ = −5 s); any [Ca2+]i spikes coinciding with
the resulting trace were considered as “triggered” by the
membrane potential spike. The code used has been deposited to
GitHub and is available upon request.
For the data in Fig. 5 and Fig. 12 D, partial area under the
curve (pAUC) was estimated exactly as previously reported
(Hamilton et al., 2018). Briefly, the recordings were split into
30-s intervals, and pAUC was calculated using trapezoidal in-
tegration for each interval.
All data are quoted as mean values ± SEM of the indicated
number of independent experiments. Statistical significances
were evaluated using Student’s t test or ANOVA followed by a
posttest (as appropriate).
Results
Glucose and tolbutamide induce electrical activity in mouse
δ-cells
The following section summarizes the basic electrophysiology
and somatostatin secretion of the pancreatic δ-cells. Membrane
potential recordings were performed on δ-cells within intact
pancreatic islets using the perforated patch whole-cell method.
When exposed to 1 mM glucose, δ-cells were hyperpolarized and
did not generate action potentials (APs). The resting membrane
potential (Vm) averaged −72 ± 2mV (n = 13 cells from 12 animals).
Elevation of glucose to 10 mM reversibly depolarized δ-cells to a
plateau potential (Vp) that averaged −55 ± 3 mV and elicited
continuous electrical activity consisting of overshooting APs that
peaked at (Vpeak) +14 ± 4 mV with a firing frequency of 0.5 ±
0.1 Hz (Fig. 1 A). δ-cells express ATP-sensitive K+-channels (KATP
channels) that are of the same molecular identity (Kcnj11 for
Kir6.2, and Abcc8 for Sur1) and comparable expression levels to
those found in β-cells (Adriaenssens et al., 2016; DiGruccio et al.,
2016). A saturating concentration of the KATP channel blocker
tolbutamide (200 µM, half-maximal inhibition observed at
7 µM; Trube et al., 1986) exerted a glucose-like effect on δ-cell
electrical activity: It depolarized the δ-cells and evoked AP fir-
ing. The APs originated from a Vp of −46 ± 3 mV (n = 13 cells from
12 animals; P < 0.01 vs. 10 mM glucose), had a Vpeak of +5 ± 2 mV
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(P < 0.01 vs. 10 mM glucose), and occurred at a frequency of
0.8 ± 0.1 Hz. The ∼10 mV drop in the peak voltage of the APs in
response to tolbutamide is likely the consequence of the more
depolarized Vp, with consequential steady-state inactivation of
the voltage-gated Na+ channels involved in AP firing (Go¨pel
et al., 2000; Zhang et al., 2014b). In fact, the tolbutamide-
induced membrane depolarization was strong enough to sup-
press AP firing in some cells (2 out of 13 cells; Fig. 1 A, inset), an
effect reminiscent of that observed upon application of the Na+
channel blocker tetrodotoxin (Zhang et al., 2014b).
Membrane potential–independent glucose-induced
stimulation of somatostatin release
Although tolbutamide and glucose were equipotent in stimulat-
ing δ-cell electrical activity, glucose was a considerably stronger
stimulus of somatostatin secretion (Fig. 1 B). Whereas tolbuta-
mide (200 µM) stimulated somatostatin release 1.4 ± 0.2–fold
above basal, glucose (10 mM) produced a 3.6 ± 0.3–fold increase.
Exocytosis in δ-cells is voltage-dependent and increases
steeply between −20 and 0 mV, but there is little difference
between 0 and +20 mV (Zhang et al., 2007). This suggests that
the ∼10-mV reduction in AP Vpeak (from +13 to +4 mV) cannot
account for the finding that tolbutamide is a much weaker
stimulus of somatostatin secretion than glucose. Thus, it is more
likely that glucose augments δ-cell exocytosis by an additional
intracellular signal. We next explored this aspect by measuring
somatostatin in islets depolarized by a supraphysiological con-
centration of [K+]o (70 mM) to bypass electrical activity.
At low glucose (1 mM), high [K+]o stimulated somatostatin
secretion 1.8 ± 0.1–fold above basal ([K+]o = 3.6 mM). Addition
of 20 mM glucose induced a further 3.2 ± 0.2–fold amplifi-
cation of somatostatin release (Fig. 1 C). We ascertained that
increasing glucose from 1 mM to 20 mM had no effect on δ-cell
membrane potential in the presence of 70 mM [K+]o (−14 ±
2 mV and −14 ± 3 mV, respectively; n = 3 cells from two ani-
mals; Fig. 1, D and E).
Figure 1. δ-cell electrical activity and somatostatin
secretion. Relative roles of membrane depolarization
and intracellular events in the regulation of somatostatin
release–membrane depolarization in the absence of
glucose is a weak stimulus for somatostatin secretion.
(A) Electrical activity recorded from a δ-cell within an
intact islet exposed to 1 mM glucose, 10 mM glucose, or
200 µM tolbutamide as indicated. The recording shown
is representative of 11 out of a total 13 similar inde-
pendent experiments. Zero mV is indicated by the red
dashed line. Right panel shows examples of single action
potentials recorded in 10 mM glucose (black) or tolbu-
tamide (red) on an expanded time scale. Inset: Transient
stimulation of electrical activity by tolbutamide in a
δ-cell exposed to 1 mM glucose (seen in 2 out of 13
experiments). (B) Somatostatin secretion measured at
1 mM glucose (n = 20), 1 mM glucose in the presence of
0.2 mM tolbutamide (n = 10), and 10 mM glucose (n =
20) as indicated. *, P < 0.05 vs. 1 mM glucose; †, P < 0.05
vs. 0.2 mM tolbutamide. Islets are from more than three
animals for each experiment, and n represents the
number of independent experiments. fmol islet−1h−1,
femtomole per islet per hour. (C) Somatostatin secretion
measured at 3.6 mM [K+]o with 1 mM glucose (n = 10)
and at 70 mM [K+]o with 1 mM (n = 42) or 20 mM glu-
cose (n = 20) as indicated. *, P < 0.05 vs. 1 mM glucose at
3.6 mM [K+]o; †, P < 0.05 vs. 1 mM glucose at 70mM [K+]o.
Islets were from more than three animals for each ex-
periment, and n represents the number of independent
experiments. (D) Electrical activity of a δ-cell in response
to physiological (3.6 mM) or supraphysiological (70 mM)
[K+]o (solid red lines) at 1 mM or 20 mM glucose (black
line). Note that high [K+]o depolarized the δ-cell to iden-
tical membrane potential in the presence of 1 mM or
20mMglucose (dashed red line). The recording represents
three independent experiments of identical conditions.
(E) Bar graph summarizing effects of glucose and [K+]o as
indicated. *, P < 0.05 vs. 1 mM glucose at the same [K+]o;
††, P < 0.01; and †††, P < 0.001 vs. 3.6 mM [K+]o with the
same glucose concentration. All membrane potential re-
cordings were performed using the perforated patch
clamp technique. In B, C, and E, data are presented as
mean ± SEM of the number of independent experiments.
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Collectively, these data suggest that although membrane de-
polarization as such (produced by tolbutamide or 70 mM [K+]o)
is capable of stimulating somatostatin secretion from δ-cells,
most of the stimulation produced by glucose (>75%) is instead
attributable to an amplifying effect of glucose, exerted beyond
membrane depolarization and electrical activity.
Glucose increases δ-cell cytoplasmic cAMP
In α- and β-cells, glucose has been reported to elevate cyto-
plasmic cAMP ([cAMP]i; Tian et al., 2011). We next tested
whether glucose also increases [cAMP]i production in δ-cells
and whether the nucleotide is responsible for transducing glu-
cose metabolism into the amplifying signal for GISS. The fol-
lowing sections summarize the effects of glucose on δ-cell
[cAMP]i and the effects of cAMP on GISS, δ-cell exocytosis,
and [Ca2+]i dynamics (Figs. 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11).
First, we used a genetically encoded cAMP indicator, Epac2-
camps, for time-lapse measurements of [cAMP]i in isolated
single tdRFP-expressing δ-cells. Cells without tdRFP expression
represent a mixture of insulin-secreting β-cells and glucagon-
secreting α-cells but principally (∼85%) consist of β-cells
(Cabrera et al., 2006). The function of the FRET sensor was
validated bymeasuring its response to adenylyl cyclase activator
forskolin (2.5 µM) in non–δ- and δ-cells. Forskolin reversibly
increased the fluorescent intensity of the FRET donor (CFP) with
a concomitant reduction in YFP (acceptor) intensity. The re-
sultant change in CFP/YFP indicates the changes in [cAMP]i
(Fig. 2 A). In a series of 10 experiments, elevating glucose from
1 to 20 mM increased [cAMP]i in δ-cells to approximately the
same extent as in non–δ-cells, but less than the increase pro-
duced by 2.5 µM forskolin (Fig. 2, B and C).
Next, to translate these changes in Epac2-camps signal to
actual cAMP concentrations, we correlated changes in total islet
cAMP content to stimulation of somatostatin secretion by
measuring these two parameters in islets exposed to 1 mM
glucose or 10 mM glucose (Fig. 2 D). To study the effect of
electrical activity as such on cAMP content, we used 0.2 mM
tolbutamide applied in the presence of 1 mM glucose.
Increasing extracellular glucose concentration from 1 to
10mMpromoted islet cAMP production >200% (from a basal 0.9
Figure 2. Glucose- and forskolin-induced increases in cytoplasmic cAMP. Effects of glucose on δ-cell cAMP–glucose elevates δ-cell intracellular cAMP.
(A) Representative recordings of changes in CFP (blue traces, F/F0) and YFP (yellow traces, F/F0) in non–δ- (upper traces) and δ-cells (middle traces) expressing
the genetically encoded cAMP sensor Epac2-camps evoked by adding 2.5 µM forskolin (indicated by the horizontal bar). The ratio of CFP and YFP (CFP/YFP,
bottom traces) indicates cytoplasmic cAMP ([cAMP]i) in non–δ- (black trace) or δ-cells (red trace). (B) Glucose- (20 mM) and forskolin-induced (2.5 µM)
increases in [cAMP]i measured in non–δ- (black) and δ-cells (red) reported by Epac2-camps. (C) Bar graph comparing glucose- and forskolin-induced increases
in [cAMP]i in δ- (n = 10 cells; expressing tdRFP) and non–δ-cells (n = 20 cells; cells not expressing tdRFP). Responses have been normalized to the level
observed at 1 mM glucose. *, P < 0.05 vs. 1 mM glucose. (D) Relationship between islet cAMP content and somatostatin secretion measured in the presence of
1 mM (red triangle) and 10 mM glucose (red rectangle) or 0.2 mM tolbutamide (black rectangle; added at 1 mM glucose). *, P < 0.05 vs. somatostatin secretion
in presence of tolbutamide; †, P < 0.05 vs. somatostatin secretion measured at 1 mM glucose in the absence of tolbutamide. cAMP content is higher (P < 0.05) in
the presence of 10 mM glucose than at 1 mM glucose alone or 1 mM glucose in the presence of tolbutamide (n = 8 independent experiments from more than
three mice). a.u., arbitrary unit.
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to ∼3 fmol/islet). By contrast, tolbutamide did not increase islet
cAMP. Therefore, it is possible that depolarization per se is in-
sufficient to increase cAMP in δ-cells.
Glucose amplifies somatostatin secretion by cAMP-dependent
mechanisms
Because glucose increases [cAMP]i, we next tested the impact of
cAMP-dependent pathways in GISS from isolated islets. Glucose
(10 mM) augmented somatostatin release more than fourfold.
Inhibiting cAMP-dependent PKA with membrane-permeable
myristolyated PKI 14–22 (abbreviated as PKI, 1 µM) or Rp-8-
Br-cAMPS (100 µM) selectively inhibited GISS without affecting
basal somatostatin secretion (Fig. 3, A and B). Blockade of Epac2
by ESI-05 (25 µM) exerted a similar inhibitory effect on GISS
(Fig. 3 C). PKI, Rp-8-Br-cAMPS, and ESI-05 reduced the soma-
tostatin secretion in excess of basal by 68%, 78%, and 66%, re-
spectively. Because δ-cells express GLP-1 receptors (Richards
et al., 2014), a G-protein–coupled receptor that is linked to
cAMP production upon binding of GLP-1 (Thorens, 1992), we
also tested whether GLP-1 stimulates GISS (Fig. 3 D). When ap-
plied at a concentration of 100 nM, GLP-1 potentiated somato-
statin secretion evoked by 10 mM glucose by ∼50%. This effect
was abolished by the application of 100 µM Rp-8-Br-cAMPS,
which reduced somatostatin secretion below that seen in the
presence of 10 mM glucose alone (probably reflecting a PKA-
dependent component of GISS; see below).
The above experiments were conducted using physiological
[K+]o (3.6 mM). Therefore, part of the stimulatory effect of
glucose could be exerted through an increase in δ-cell electrical
activity (see Fig. 1 A). To bypass electrical activity, we next used
the high [K+]o experimental paradigm (see Fig. 1, C–E) to char-
acterize the amplifying effect of glucose/cAMP on somatostatin
secretion. Depolarization-evoked somatostatin secretion at
1 mM glucose in the absence of forskolin was not affected by
1 µM PKI, 25 µM ESI-05, or the combination of the two blockers
(Fig. 4 A). Increasing glucose from 1 mM to 20 mM (Fig. 4 A), or
addition of 2 µM forskolin (Fig. 4 B), induced a greater than
threefold increase in depolarization-evoked somatostatin se-
cretion. The stimulatory effect of glucose was reduced by >50%
in the presence of either PKI or ESI-05 (Fig. 4 A), whereas the
forskolin-stimulated somatostatin secretion was nearly com-
pletely abolished by the same blockers (Fig. 4 B). The two
blockers exerted no additive effect when applied together in the
presence of 20 mM glucose or forskolin, producing no further
inhibition compared with either PKI or ESI-05 alone (Fig. 4, A
and B).
RYR3-mediated Ca2+ release from intracellular Ca2+ stores
(ER) plays a critical role for GISS (Zhang et al., 2007). We rea-
soned that the PKA- and Epac2-dependent amplification effects
could be exerted at the level of RYR3-mediated Ca2+ release from
the ER. This is suggested by two findings: First, depletion of
intracellular Ca2+ stores by pretreatment with SERCA blocker
thapsigargin (10 µM) abolished the augmentation of somato-
statin secretion evoked by forskolin (Fig. 4 C). Second, blocking
intracellular Ca2+ release with ryanodine (50 µM) reduced the
glucose-induced amplification of depolarization-evoked soma-
tostatin secretion by 65% (Fig. 4 D), in agreement with a similar
inhibition of GISS reported previously (Zhang et al., 2007).
The inhibitory effects of ryanodine and PKI or ESI-05 were
not additive (Fig. 4 D), and applied in combination produced
an inhibition similar to that exerted by PKI or ESI-05 alone.
Finally, activating PKA and Epac2 with Sp-8-Br-cAMP
(100 µM; Schwede et al., 2015a) stimulated somatostatin
secretion to the same extent as 2 µM forskolin, whereas
the Epac2 agonist S-223 (also known as Sp-8-BnT-29-O-Me-
cAMP; 100 µM) produced an ∼60% increase in depolarization-
triggered somatostatin secretion (Fig. 4 E). The effect of
S-223 was sensitive to Epac2 antagonism by ESI-05. Unex-
pectedly, the effect of Sp-8-Br-cAMP was also fully antago-
nized by ESI-05 (Fig. 4 E).
Previous work showed that δ-cells secrete somatostatin via
Ca2+-dependent exocytosis (Zhang et al., 2007; van der Meulen
et al., 2015; Li et al., 2017). We next monitored [Ca2+]i in δ-cells
specifically expressing a genetically encoded Ca2+ indicator
GCaMP3 (from SST-GCaMP3 mouse islets; see Materials and
methods). Membrane depolarization by 70 mM [K+]o increased
[Ca2+]i (ΔF/F0) when applied at 1 mM glucose (Fig. 5 A, i).
However, this effect was transient, and ∼2 min after the onset of
the depolarization, [Ca2+]i had returned to near basal level, de-
spite the continued presence of high [K+]o (Fig. 5 A, i). The
transitory nature of the high [K+]o-induced [Ca2+]i elevation was
not due to the membrane depolarization not being maintained
(compare Fig. 1 D) but rather attributable to Ca2+- and
depolarization-dependent inactivation of the voltage-gated Ca2+
channels as previously described in β-cells (Olofsson et al.,
2002).
When the same experiment was repeated in the presence of
20 mM glucose, spontaneous [Ca2+]i spikes were observed be-
fore increasing [K+]o (Fig. 5 A, ii). The frequency of [Ca2+]i
spiking was increased by high [K+]o but, unlike what was ob-
served at 1 mM glucose, these spikes were maintained for the
entire observation period (Fig. 5 A, ii). Pretreating islets with
thapsigargin did not abolish the spontaneous [Ca2+]i spikes
evoked by high glucose at 3.6 mM [K+]o, indicating that theymay
reflect δ-cell electrical activity and the associated Ca2+ entry into
the δ-cells. However, in the islets pretreated with thapsigargin,
elevation of [K+]o in the presence of glucose evoked a smaller
response in [Ca2+]i, and the [Ca2+]i spikes were abolished within
a few minutes (Fig. 5 A, iii). We quantified these data by cal-
culating pAUC (Hamilton et al., 2018) at steady-state (during the
periods indicated by gray rectangles). This analysis indicates
that glucose more than doubles pAUC via a thapsigargin-
sensitive mechanism (Fig. 5 B).
Glucose and forskolin amplify depolarization-triggered δ-cell
exocytosis
Collectively, the data of Figs. 4 and 5 indicate that glucose and
cAMP amplify somatostatin secretion by activation of intra-
cellular ER Ca2+ release in depolarized δ-cells. To directly
monitor the impact of glucose and forskolin on δ-cell exocy-
tosis, we next measured exocytosis in δ-cells within the intact
islet using high-resolution capacitance measurements (ΔCm).
The experiments were conducted using the perforated patch
clamp configuration to maintain δ-cell metabolism.
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To determine the relationship between pulse duration and
somatostatin secretion, exocytosis was elicited by progressively
longer depolarizations (10–500 ms) from −70 mV to 0 mV. For
display purposes, only responses to 300-ms depolarizations are
shown, but similar results were evoked by both shorter and longer
depolarizations. Typically, the exocytotic response in δ-cells in-
creased with pulse duration for depolarizations <300 ms but then
plateaued during longer depolarizations (Zhang et al., 2007), as
expected for a finite number of release-competent granules. We
used this behavior to estimate the size of the IRP of granules (Eq. 1;
see Materials and methods).
In the presence of 1 mM glucose, δ-cell IRP is on average 17 ± 10
fF (Fig. 6, A and B; n = 10). Increasing extracellular glucose to 20mM
increased δ-cell IRP approximately sevenfold to 121 ± 18 fF (Fig. 6, A
and B; n = 17). Blocking glucokinase activity with mannoheptulose
(10 mM) abolished the stimulatory effect of 20 mM glucose on
exocytosis, and IRP was reduced to 29 ± 17 fF (Fig. 6, A and B; P <
0.05). Forskolin (2 µM) mimicked the effect of glucose, but the
effect was slightly weaker (not statistically significant), and IRP
averaged 77 ± 14 fF (n = 5, P < 0.05 vs. 1 mM glucose group; Fig. 6, A
and B). The IRP corresponds to the number of granules that can be
released with minimal delay (i.e., during action potential firing).
Our biophysical estimates of IRP can be converted to the number of
somatostatin-containing secretory granules using a conversion
factor of 1 fF/granule (estimated from electron microscopy; (Go¨pel
et al., 2004). Thus, IRP corresponds to∼15 granules at 1mMglucose
and increases to >100 granules in the presence of high glucose.
We considered the possibility that glucose stimulates exo-
cytosis and CICR by promoting intracellular Ca2+ storage in the
ER. This would be consistent with the strong effects of thapsi-
gargin on glucose-induced [Ca2+]i in δ-cells (see Fig. 5 A, iii; and
Fig. 5 B) and somatostatin secretion (Zhang et al., 2007). We
addressed this question by photoreleasing InsP3 from its caged
precursor (50 µM) in δ-cells preincubated at 1 or 20mM glucose
(>1 h). This is based on our previous observation that δ-cell InsP3
receptors and RYR-dependent ER Ca2+ stores communicate
(Zhang et al., 2007). In δ-cells exposed to 20 mM glucose, InsP3
triggered a Ca2+ transient (indicated by Fluo-4 fluorescence, ΔF)
that was threefold greater than that seen in δ-cells exposed to
1 mM glucose (Fig. 6, C and D). This glucose effect on InsP3-
triggered [Ca2+]i correlated with a threefold stimulation of the
initial rate of exocytosis (Fig. 6, E and F; expressed as δCm/δt; P <
0.05 vs. 1 mM glucose), suggesting that glucose promotes se-
questration of Ca2+ into the ER. In addition, these data provide
direct evidence that intracellular Ca2+ release is sufficient to
elicit exocytosis in δ-cells.
cAMP augments depolarization-evoked exocytosis and
increases [Ca2+]i in δ-cells
CICR plays a critical role in somatostatin secretion from δ-cells
(Zhang et al., 2007; Li et al., 2017). We next examined the impact
of intracellular cAMP on the depolarization-evoked [Ca2+]i
transients and cellular exocytosis in δ-cells (Fig. 7). In this series
of experiments, we used standard whole-cell configuration,
Figure 3. Glucose-stimulated somatostatin secre-
tion by PKA or Epac2 activation. PKA- and Epac2-
dependent pathways are involved in the regulation of
somatostatin secretion. (A) Somatostatin secretion
measured in islets exposed to 1 and 10 mM glucose
under control condition or in the presence of 1 µM
myristoylated PKI as indicated. (B) As in A, but the effect
of Rp-8-Br-cAMPS (100 µM) was tested. (C) As in A, but
the effect of 25 µM ESI-05 was tested. (D) As in A, but
the effect of 100 nM GLP-1 on 10 mM glucose-
stimulated somatostatin secretion in the presence or
absence of Rp-8-Br-cAMPS (100 µM) was tested. In
A–D, data are presented as mean values ± SEM for the
indicated number of independent experiments (n). *, P <
0.05 and ***, P < 0.001 vs. 1 mM glucose with the same
conditions; †, P < 0.05; ††, P < 0.01; and †††, P < 0.001 vs.
10 mM glucose alone (as indicated); ‡, P < 0.05 vs.
10 mM glucose in the presence of 100 nM GLP-1. [K+]o
was 3.6 mM for all the experiments, and islets were from
more than three animals for each experiment.
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which allows direct intracellular application of a Ca2+ indicator
(indo-1) and cAMP through patch clamp electrodes. The δ-cells
were stimulated by a series of progressively longer depolariza-
tions (for 10–500 ms, from −70 mV to 0 mV), applied with an
interval of 20 s.
We determined the impact of cAMP on basal [Ca2+]i, peak
[Ca2+]i, and duration of the spike (Fig. 7, B and D; and Table 2)
and correlated the changes to exocytotic capacity (Fig. 7, A and C,
measured as IRP). cAMP effects on exocytosis and basal [Ca2+]i
were undetectable at 1 µM, half-maximal at 3 µM, and maximal
at ≥10 µM (Fig. 7, A–D). At high [cAMP]i (≥10 µM), IRP increased
more than fourfold, and basal [Ca2+]i increased from ∼50 nM to
∼200 nM (Fig. 7, C and D). Increasing [cAMP]i from 0 to 100 µM
also increased peak [Ca2+]i by ∼100% and extended the duration
of the spikes (half width) by >50% (Table 2). This effect is not
due to changes in Ca2+ currents induced by cAMP. Ca2+ current
measured in response to a depolarization (from −70 mV to 0
mV) in the presence of 100 µM cAMP was −70 ± 7 pA (n = 7),
which was marginally less than, though not statistically differ-
ent from, that recorded in the absence of cAMP (−80 ± 7 pA; n =
12). Pretreatment with thapsigargin abolished the effect of
100 µM cAMP on both exocytosis and [Ca2+]i (red traces in Fig. 7,
Figure 4. PKA- and Epac2-dependent effects of glucose and forskolin on depolarization-induced somatostatin secretion by ER Ca2+ release. PKA- and
Epac2-dependent intracellular Ca2+ release is involved in somatostatin secretion in depolarized δ-cells—an effect that is independent of membrane depo-
larization. (A) Somatostatin secretion in response to 1 mM and 20 mM glucose in islets depolarized with 70 mM [K+]o under control conditions and in the
presence of PKI (1 µM), ESI-05 (25 µM), or both blockers, as indicated. ***, P < 0.001 vs. 1 mM glucose under same condition; ††, P < 0.01 and †††, P < 0.001 vs.
20 mM glucose alone. (B) Somatostatin secretion measured in the absence and presence of 2 µM forskolin (at 1 mM glucose) in islets depolarized with 70 mM
[K+]o. Effect of PKI (1 µM), ESI-05 (25 µM), or simultaneous application of both blockers on forskolin-stimulated somatostatin secretion was tested. *, P < 0.05
and ***, P < 0.001 vs. somatostatin secretion under control condition; †††, P < 0.001 vs. somatostatin in the presence of 2 µM forskolin alone. (C) As in B but
testing the effect of preincubation with thapsigargin (10 µM, 1 h) on 2 µM forskolin-stimulated somatostatin secretion (triggered by 70 mM [K+]o). ***, P <
0.001 vs. somatostatin secretion under the control condition; †††, P < 0.001 vs. somatostatin secretion in the presence of 2 µM forskolin alone. (D) Soma-
tostatin secretion in response to 1 mM and 20mM glucose in islets depolarized with 70mM [K+]o under control condition and in the presence of ryanodine, PKI
or ESI-05 as indicated. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 vs. 1 mM glucose alone; †††, P < 0.001 vs. 20 mM glucose alone. (E) 70 mM [K+]o-triggered
somatostatin secretion measured in the absence and presence of forskolin (2 µM), Sp-8-Br-cAMP (100 µM), or Epac2 agonist (S-223, 100 µM). ESI-05 (25 µM)
was applied in the presence of Sp-8-Br-cAMP or S-223 to test the specificity of the agonists. ***, P < 0.001 vs. somatostatin secretion under the control
condition; †††, P < 0.001 vs. somatostatin secretion in the presence of 100 µM Sp-8-Br-cAMP alone; and ‡‡‡, P < 0.001 vs. somatostatin secretion in the
presence of 100 µM S-223 alone. In A–E, data are presented as mean values ± SEM for the indicated numbers of independent experiments (n). Islets frommore
than three animals were used for each experiment.
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A and B; red rectangles in Fig. 7, C and D; and Table 2). We note
that the thapsigargin effect on exocytosis observed here appears
slightly stronger than that in our previous report (Zhang et al.,
2007), a difference that may reflect different extracellular sol-
utions used in this and the previous study (1 mM and 20 mM
glucose, respectively).
Consistent with our previous report (Zhang et al., 2007), the
depolarization-triggered capacitance increases extended beyond
the duration of depolarizations when the experiments were
performed in the presence of cAMP (slow component of exo-
cytosis, indicated by arrows in Fig. 7 A). This component of
exocytosis was abolished by pretreatment with thapsigargin and
absent when [cAMP]i was ≤1 µM. The slow component of exo-
cytosis correlated with a prolongation of the depolarization-
evoked [Ca2+]i increases in the presence of cAMP, which was
sensitive to thapsigargin (Fig. 7 B). In the absence of cAMP, the
[Ca2+]i peaked within <200 ms after the end of the depolariza-
tion, which was followed by a smooth decay toward the baseline
(Fig. 7 B). By contrast, in the presence of 100 µM cAMP, the
δ-cell [Ca2+]i continued to increase and did not decline until
>500ms after the end of the depolarization. This correlated with
an approximately threefold increase in [Ca2+]i transients area
under the curve (AUC) compared with the control (P < 0.05;
Fig. 7 D, inset). These effects of cAMP were prevented by pre-
treatment with thapsigargin (Fig. 7 B), and the [Ca2+]i transients
AUC was reduced to a level close to the control.
To further confirm the intracellular nature of the effect of
cAMP on δ-cell exocytosis and CICR, wemeasured depolarization-
triggered [Ca2+]i transients and exocytosis in SST-GCaMP3 δ-cells
before and after the application of forskolin, using the perforated
patch configuration. In a series of five experiments, exposure to
10 µM forskolin for 5 min significantly augmented [Ca2+]i tran-
sients triggered by 300-ms depolarizations from −70 to 0 mV
(Fig. 7 E; P < 0.05). The increase in [Ca2+]i transient magnitude
correlated with an approximately fourfold increase in δ-cell exo-
cytosis (from 9 ± 2 fF to 38 ± 10 fF; n = 5; P < 0.05). Interestingly,
the adenylyl cyclase activator also induced spontaneous [Ca2+]i
spikes (arrows in Fig. 7 E, inset) in δ-cells voltage-clamped
at −70 mV (to prevent opening of voltage-gated Ca2+ channels).
Together, the data in Fig. 7 demonstrate that increases in intra-
cellular cAMP enhance depolarization-evoked CICR and exocyto-
sis in δ-cells.
cAMP induces spontaneous [Ca2+]i spikes in δ-cells
Consistent with the data in Fig. 7 E, intracellular application of
cAMP also induced spontaneous Ca2+ spikes in δ-cells (indicated
by arrows in Fig. 8, C and D). In cells infused with 10–100 µM
cAMP, 67% of the δ-cells (six of nine cells from eight animals)
displayed Ca2+ transients even when voltage-clamped at −70 mV
but were seen in ∼30% of the δ-cells (4 of 14 cells) dialyzed with
a solution containing ≤1 µM cAMP (Fig. 8, A and B). Variable in
duration, the magnitude of these spikes was comparable to the
increase in [Ca2+]i produced by a 10-ms depolarization from −70
to 0mV (Fig. 8, C and D). The cAMP-induced spontaneous [Ca2+]i
spikes were abolished by pretreating islets with 10 µM thapsi-
gargin (Fig. 8 E). We point out that these [Ca2+]i spikes are not
apparent in the traces in Fig. 7 B, in which the data for several
cells have been averaged. Depletion of ER Ca2+ with thapsigargin
was not associated with any detectable increase in the holding
current at −70 mV (not shown). Thus, store-operated Ca2+ influx
plays little or no role in the δ-cells under the experimental
conditions pertaining to these experiments.
The spontaneous δ-cell [Ca2+]i spikes in the presence of cAMP
may contribute to the cAMP-induced increase in δ-cell basal
[Ca2+]i. Next we tested whether changes in basal [Ca2+]i alone
would affect δ-cell exocytosis. We did this by clamping [Ca2+]i
Figure 5. Glucose-stimulated [Ca2+]i oscillations in high [K+]o-depolarized δ-cells. δ-cell Ca2+ release from the ER is stimulated by glucose. (A) Examples
of δ-cell [Ca2+]i (ΔF/F0) recorded from SST-GCaMP3 islets in response to increasing [K+]o from 3.6 mM to 70 mM as indicated. Experiments were conducted
with extracellular media containing (i) 1 mM glucose and (ii) 20 mM glucose in islets cultured in control RPMI medium; and (iii) 20 mM glucose in islets incubated
with RPMI medium containing 10 µM thapsigargin (>1 h). (B) Summary of 70 mM [K+]o-triggered δ-cell [Ca2+]i (pAUC) at steady-state (gray areas in A) under
the experimental conditions indicated below. *, P < 0.05 vs. 1 mM glucose and †, P < 0.05 vs. 20 mM glucose without pretreatment of thapsigargin. Data are
presented as mean values ± SEM of the indicated numbers of GCaMP3-expressing δ-cells (n) from two or three mice for each experimental condition. AU,
arbitrary unit.
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through infusion via the patch pipettes of an intracellular solution
containing 103 nM or 240 nM free Ca2+ but no cAMP for 5 min
preceding a depolarization (from −70mV to 0mV for 500ms) that
triggered exocytosis. This moderate increase in basal [Ca2+]i stim-
ulated depolarization-evoked exocytosis by 80% (Fig. 9, A and B).
Does an increase in basal [Ca2+]i enhance δ-cell CICR? We
tested this by measuring the [Ca2+]i transients triggered by 500-
ms depolarizations (from −70 to 0 mV) before and after a pro-
longed (2 min) low-amplitude depolarization (from −70 to −40
mV). This set of experiments was conducted in δ-cells in islets
from SST-GCaMP3 mice exposed to 1 mM glucose using the
perforated patch clamp technique. As shown in Fig. 9 C, the
moderate depolarization produced a moderate but sustained
increase in [Ca2+]i, but the second pulse to 0 mV did not trigger
larger [Ca2+]i increases than the first pulse (Fig. 9, C and D).
Therefore, at low glucose, it is not apparent that an increase in
basal [Ca2+]i per se is sufficient to enhance δ-cell CICR.
cAMP-dependent δ-cell exocytosis relies on CICR
The observed cAMP effect can be mediated by PKA- or Epac2-
dependent pathways, and blocking the two cAMP effectors
strongly inhibited GISS (see Figs. 3 and 4). We next analyzed the
contribution of PKA- and Epac2-mediated mechanisms in the
control of δ-cell exocytosis and [Ca2+]i. The Epac2 agonist 29-O-
Me-cAMP (100 µM) or cAMP (100 µM) was infused into δ-cells
via the patch pipettes during standard whole-cell measurements,
in the absence or presence of inhibitors of PKA (PKI; 1 µM) or
Epac2 (ESI-05; 25 µM).
Figure 6. Glucose metabolism stimulates exocytosis and ER Ca2+ uptake in δ-cells. Exocytosis and ER Ca2+ uptake in δ-cells are stimulated by glucose
metabolism or forskolin. (A) Exocytosis (measured as increases in membrane capacitance, bottom traces, ΔCm) triggered by 300-ms depolarizations from
−70 mV to 0 mV (top) in δ-cells exposed to indicated experimental conditions (red). The black traces show the exocytotic responses triggered by identical
pulses in the same cells exposed to 1 mM glucose alone. The experiments were conducted using perforated patch whole-cell configuration. (B) Summary of
exocytotic response (IRP) in δ-cells perfused with extracellular solutions containing glucose (1 mM and 20 mM), forskolin (2 µM), and 10 mMmannoheptulose
in the presence of 20 mM glucose. *, P < 0.05 vs. 1 mM glucose and †, P < 0.05 vs. 20 mM glucose alone. Data are mean values ± SEM of indicated number of
independent experiments (n) from 2–14 animals. (C) Increase in [Ca2+]i (ΔF) triggered by photorelease of caged InsP3 precursor in δ-cells preincubated at 1 mM
(black) or 20 mM glucose (red) for >1 h. Photoliberation was effected by a flash of UV light as indicated. Traces are representative responses of similar in-
dependent experiments (n = 4 for 1 mM and 20 mM glucose). (D) Summary of data in C. *, P < 0.05 vs. 1 mM glucose. Data are mean values ± SEM of four
independent experiments from two to four animals for each experimental condition. (E) As in C but shows the δ-cell exocytosis (ΔCm) in response to pho-
toliberation of InsP3. Pre-incubation glucose concentrations are as indicated. The dotted lines indicate the slope of initial capacitance increase. (F) Summary of
the initial exocytotic rate (δCm/δt) following photorelease of InsP3 in δ-cells preincubated at 1 mM or 20 mM glucose for >1 h. *, P < 0.05 vs. 1 mM glucose. The
exocytotic rate was calculated by differentiating the rising slope of capacitance increase in response to increases in cytosolic InsP3. Data are mean values ± SEM
of four independent experiments from two to four animals for each experimental condition. In C–F, experiments were conducted using standard whole-cell
technique without addition of cAMP in the intracellular solution.
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The stimulatory effect of 100 µM cAMP on δ-cell exocytosis
(blue traces in Fig. 10 A and blue dotted line in Fig. 10 C) was re-
duced by 70% in the presence of PKI or ESI-05. Whereas ESI-05
counteracted the effect of cAMP on basal [Ca2+]i to the same extent
as thapsigargin (compare Fig. 7, C and D), PKI had no effect (Fig. 10,
B and D; and Table 2). Selective activation of Epac2 by 100 µM 29-
O-Me-cAMP had similar effects on [Ca2+]i as cAMP in the presence
of PKI: It increased basal [Ca2+]i and broadened the Ca2+ transients
but did not affect peak [Ca2+]i (Fig. 10, B and D; and Table 2). In
addition, whereas the spontaneous cAMP-induced [Ca2+]i spikes
were abolished by ESI-05, they persisted in δ-cells infused with
29-O-Me-cAMP or cAMP with addition of PKI (Fig. 10, E–G).
In the presence of PKI, the depolarization-evoked [Ca2+]i transients
were sometimes distinctly biphasic with a secondary increase
(red arrows in Fig. 10 F) occurring with a delay of ≈2 s (2 out of
10 cells). This was echoed by the similar observation (red arrows in
Fig. 10 E) in 67% of the δ-cells (four out of six cells) infusedwith the
Epac2 agonist 29-O-Me-cAMP (100 µM). It may be speculated that
some basal PKA activity is required for efficient coupling between
Ca2+ entry and Epac2/RYR3-dependent activation of CICR.
Figure 7. cAMP-dependent increases in exocytosis and basal [Ca2+]i in δ-cells. Correlation between [cAMP]i and δ-cell [Ca2+]i/exocytosis. (A) Exocytosis
(ΔCm; bottom) evoked by 300-ms depolarizations from −70 mV to 0 mV (top) in δ-cells dialyzed with cAMP at the indicated concentrations. Red trace shows
the response with 100 µM cAMP following treatment with 10 µM thapsigargin. (B) As in A but showing the changes in cytoplasmic [Ca2+]i (on a compressed
timescale). Gray areas mark the periods of 300-ms membrane depolarizations from −70 mV to 0 mV. Note that [Ca2+]i traces are averaged responses of
experiments of the same conditions. (C) Summary of cAMP dose-dependent effect on δ-cell immediate releasable pool (IRP; n = 14 independent experiments
for control, 6 for 1 µM cAMP, 5 for 10 µM cAMP, 6 for 100 µM cAMP, and 4 for 100 µM cAMP pretreated with 10 µM thapsigargin; ***, P < 0.001 vs. control).
Red rectangle indicates the response with 100 µM cAMP following pretreatment with 10 µM thapsigargin for > 1 h. ††, P < 0.01 vs. 100 µM cAMP alone. (D) As
in C but summarizes the response of basal [Ca2+]i (n = 9 independent experiments for control, 5 for 1 µM cAMP, 3 for 10 µM cAMP, 5 for 100 µM cAMP, and 4
for 100 µM cAMP pretreated with 10 µM thapsigargin for >1 h; *, P < 0.05 and ***, P < 0.001 vs. control). Red rectangle indicates the response with 100 µM
cAMP following pretreatment with 10 µM thapsigargin. ††, P < 0.01 vs. 100 µM cAMP alone. In C and D, data are presented as mean values ± SEM for the
number of independent experiments (n) from two to eight animals. Inset summarizes the AUC of depolarization-triggered [Ca2+]i transients in δ-cells infused
with cAMP of the indicated concentrations. Red bar shows the response in thapsigargin-pretreated δ-cells infused with 100 µM cAMP. Data are mean values ±
SEM for the number of independent experiments (n) from two to eight animals. *, P < 0.05 vs. control and †, P < 0.05 vs. 100 µM cAMP without thapsigargin
pretreatment. (E) Bar graph shows the average AUC of [Ca2+]i transients triggered by 300-ms depolarizations before (black) and after application of 10 µM
forskolin (red). Data are presented as mean values ± SEM of indicated numbers of independent experiments (n) from two animals. *, P < 0.05 vs. control (before
forskolin application). Inset shows examples of 300-ms depolarizations (from −70 to 0 mV) triggered δ-cell [Ca2+]i transients, recorded in the same cells, before
(control, black) and after the application of forskolin (forskolin, red) for 5 min. Onset of the depolarizing pulses is indicated by vertical dotted lines. Arrows
indicate spontaneous Ca2+ spikes that were observed in the absence of membrane depolarization. The traces are aligned to the same baseline to facilitate the
comparison of [Ca2+]i transient kinetics. Measurements in A–D were conducted using the standard whole-cell technique. Experiments in E were conducted
using perforated patch clamp technique.
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The effects of ESI-05 on cAMP-induced stimulation of exo-
cytosis and basal [Ca2+]i were echoed by the results of genetic
ablation of Epac2. In δ-cells from Epac2 knockoutmice (Epac2−/−),
basal [Ca2+]i was not increased by intracellular application of
100 µM cAMP, unlike what was observed in wild-type (Epac2+/+)
δ-cells (Fig. 11 A). The effects of ablating Epac2 on [Ca2+]i
were paralleled by reduced cAMP-induced augmentation of
depolarization-evoked exocytosis compared with Epac2+/+
δ-cells (Fig. 11 B). These changes correlate with reduced GISS
(Fig. 11, C and D). Whereas 200 µM tolbutamide produced a
similar stimulation of somatostatin secretion from both Epac2+/+
and Epac2−/− islets, GISS from Epac2−/− islets was ∼20% lower
than that seen in the Epac2+/+ islets (P < 0.05). Inhibition of PKA
with Rp-8-Br-cAMPS abolished GISS in Epac2−/− islets and
reduced secretion to a level below that evoked by tolbutamide








0 n/a 185 ± 60 226 ± 30 8
1 n/a 347 ± 88 207 ± 17 5
10 n/a 326 ± 35 282 ± 17 3
100 n/a 353 ± 56a 347 ± 36a 5
0 100 µM 29-O-Me-
cAMP
232 ± 34b 465 ± 121a 7
100 10 µM thapsigargin 286 ± 45 301 ± 12 4
100 1 µM myr-PKI 347 ± 53a 558 ± 106a 6
100 25 µM ESI-05 225 ± 39 291 ± 34 4
Peak ([Ca2+]peak) and duration (half width) of [Ca2+]i transients triggered by
300-ms depolarizations from −70 mV to 0 mV in δ-cells infused with
intracellular solutions containing cAMP with concentrations indicated. The
Treatment column lists the compounds that were infused into δ-cells at
the indicated concentrations in the presence of 100 µM cAMP (with the
exception of thapsigargin, which was applied extracellularly during the
pretreatment of the islets). Data are presented as mean values ± SEM of
indicated number of independent experiments (n) from two to eight animals.
All the measurements were made using standard whole-cell technique. n/a,
not applicable.
aP < 0.05 vs. control (no addition of cAMP).
bP < 0.05 vs. 100 µM cAMP alone.
Figure 9. Elevation of basal [Ca2+]i potentiates δ-cell exocytosis but not
CICR. (A) Moderate elevation of [Ca2+]i potentiates exocytosis but not CICR.
Exocytosis (ΔCm, lower) triggered by 500-ms depolarizations from −70 to
0 mV (Vm, top) in δ-cells infused with 103 nM or 240 nM free Ca2+ through
patch pipettes. (B) Bar graph summarizing the effects of indicated number of
independent experiments (n) from two or three animals for each condition. *,
P < 0.05 vs. 103 nM [Ca2+]i. (C) δ-cell [Ca2+]i transients (lower, ΔF/F0) trig-
gered by 500-ms depolarizations (from −70 to 0 mV) before (pulse 1) and
after (pulse 2) a 2-min depolarization from −70 to −40 mV (top). The average
AUC of [Ca2+]i transients triggered by pulses 1 and 2 of indicated number of
independent experiments (n, from three animals) are summarized in D. Ex-
periments in A and B were conducted using standard whole-cell technique.
Data in B and D are presented as mean ± SEM of the numbers of independent
experiments as indicated. Experiments in C and D were conducted using
perforated patch clamp technique.
Figure 8. Spontaneous cAMP-dependent [Ca2+]i
transients in voltage-clamped δ-cells. Spontaneous
thapsigargin-sensitive [Ca2+]i spikes evoked by cAMP.
(A–D) [Ca2+]i recorded in δ-cells held at −70 mV and
infused with cAMP (concentrations as indicated) using
the standard whole-cell technique. Three consecutive
depolarizations from −70 mV to 0 mV with increasing
durations were applied: 10 ms (black dotted lines),
20 ms (blue dotted lines), and 50 ms (red dotted lines).
Depolarizations were applied with >20-s intervals.
(E) As in D but after preincubation with 10 µM thapsi-
gargin for >1 h. Responses are normalized to the [Ca2+]i
increase evoked by a 50-ms depolarization to 0 mV.
Recordings are representative of six (A), five (B), three
(C), five (D), and four (E) independent experiments from
two to five animals. Arrows above traces indicate the
spontaneous [Ca2+]i spikes.
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(P < 0.05). By contrast, 60% of GISS was resistant to the PKA
inhibitor in Epac2+/+ islets (P < 0.05; Fig. 11, C and D). This
suggests that Rp-8-Br-cAMPS specifically inhibits PKA and does
not exert a nonspecific action on Epac2, which is different from
an observation made using an in vitro assay with purified pro-
teins (Schwede et al., 2015b).
Glucose and forskolin induce membrane
potential–independent [Ca2+]i transients in δ-cells
The final sections deal with the relationship between δ-cell
membrane potential and [Ca2+]i dynamics (Figs. 12, 13, and 14).
The finding that tolbutamide is a weaker stimulus of somato-
statin secretion than glucose, despite the two compounds having
Figure 10. PKA-dependent and -independent effect of cAMP on δ-cell exocytosis. PKA and Epac2 differentially regulate depolarization-evoked exocytosis
and [Ca2+]i increase. (A) Exocytosis (ΔCm; bottom) evoked by 300-ms depolarizations from −70 mV to 0 mV (top) in δ-cells dialyzed with cAMP (100 µM)
together with inhibitors of PKA (PKI, 1 µM), Epac2 (ESI-05, 25 µM), or Epac2 agonist (29-O-Me-cAMP, 100 µM) alone as indicated. (B) The averaged [Ca2+]i
responses of experiments of the same conditions. In A and B, red and blue traces represent responses seen in control (without cAMP) and 100 µM cAMP,
respectively, and are inserted here for comparison. Note that different time scales are used for the electrophysiological measurements and recordings of [Ca2+]i.
Gray rectangles correspond to the 300-ms depolarizations from −70 to 0 mV. (C and D) IRP and basal [Ca2+]i determined under the indicated experimental
conditions. Data aremean values ± SEM for indicated number of independent experiments (n) from 4–15 animals for each experimental condition. †, P < 0.05 and
††, P < 0.01 vs. 100 µM cAMP. Red and blue dotted lines indicate responses seen in control (without cAMP) and 100 µM cAMP, respectively. (E) [Ca2+]i recorded
in δ-cells held at −70 mV and infused with Epac2 agonist (29-O-Me-cAMP, 100 µM). Three consecutive depolarizations from −70 mV to 0 mV were applied
with increasing durations: 10 ms (black dotted lines), 20 ms (blue dotted lines), and 50 ms (red dotted lines). Depolarizations were applied with >20-s intervals.
(F and G) As in E, but cells were infused with solutions containing 100 µM cAMPwith inclusion of PKI (1 µM; F) or ESI-05 (25 µM; G). Responses were normalized
to the 50-ms depolarization-triggered [Ca2+]i transients. Recordings are representative of 7 (E), 10 (F), and 5 (G) independent experiments from four to eight
animals. Black arrows above the traces indicate the spontaneous [Ca2+]i spikes before depolarization, and red arrows indicate the second increase in [Ca2+]i
following depolarizations. All measurements were made using the standard whole-cell technique.
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similar effects on δ-cell AP firing, suggests that the relationship
between electrical activity and exocytosis is complex. To explore
this aspect further, we performed parallel measurements of
glucose-induced electrical activity and [Ca2+]i in δ-cells. These
experiments were performed by perforated patch membrane
potential recordings in δ-cells from SST-GCaMP3 mice.
Consistent with the data in Fig. 1, elevation of glucose from
1 mM to 10 mM produced membrane depolarization and initi-
ated regenerative electrical activity in δ-cells (Fig. 12 A). Inter-
estingly, [Ca2+]i oscillations measured in parallel did not show a
strong correlation to electrical activity (Fig. 12 B). In fact, in 36%
of the cells recorded (4 of 11 cells), [Ca2+]i oscillations preceded
glucose-induced AP firing. Furthermore, in the presence of high
glucose, the majority of [Ca2+]i spikes (63 ± 12%; n = 4 cells from
four animals) could not be attributed to any preceding APs
(Fig. 12 B, i).
We classified the [Ca2+]i spikes into “triggered” (highlighted
in red in Fig. 12, A and B) and “spontaneous” events (black),
according to the time delay between the [Ca2+]i spike and the
nearest preceding APs (see Materials and methods). The am-
plitude and duration of the “spontaneous” and “triggered” [Ca2+]i
spikes in high glucose were very variable, and although the
“spontaneous” events tended to be smaller, this difference did
not attain statistical significance (Fig. 12 C). Upon washout of
glucose, [Ca2+]i spikes were reduced in amplitude (Fig. 12 D) and
demonstrated a stronger correlation with the residual APs, with
the majority of the events being “triggered” (62 ± 12%; Fig. 12 B,
ii). The mechanism behind this “hysteresis” remains to be
elucidated.
Membrane potential–independent δ-cell [Ca2+]i spikes involve
Epac2 and are sensitive to thapsigargin
The above data indicate that δ-cell [Ca2+]i spikes induced by high
glucose cannot be attributable to AP-mediated Ca2+ influx
through opening of voltage-gated Ca2+ channels alone. To char-
acterize the glucose effect on membrane potential–independent
[Ca2+]i spikes, we measured [Ca2+]i in SST-GCaMP3 δ-cells that
were voltage clamped at Vm (−70 mV) to eliminate AP firing.
This series of experiments was also conducted using the per-
forated patch whole-cell voltage-clamping technique to pre-
serve metabolism.
In δ-cells voltage clamped at −70 mV, glucose (20 mM)
remained capable of inducing [Ca2+]i spikes (Fig. 13 A). These
[Ca2+]i spikes reflect Ca2+ release from the ER and were not
seen in δ-cells in islets pretreated with thapsigargin (Fig. 13
B). The glucose-induced [Ca2+]i spikes in voltage-clamped
δ-cells were also abolished in islets pretreated with ESI-05,
which exerted a thapsigargin-like effect (Fig. 13 C). By con-
trast, the spontaneous spikes persisted after pretreatment
with PKI (Fig. 13 D).
Figure 11. Ablation of Epac2 (Rapgef4) reduces depolarization-triggered [Ca2+]i, exocytosis and GISS in δ-cells. Somatostatin secretion, depolarization-
triggered [Ca2+]i increases, and exocytosis in Epac2-deficient δ-cells. (A) Summary of basal [Ca2+]i measured in the presence and absence of 100 µM cAMP in
δ-cells from control (Epac2+/+, filled bars) and Epac2 KO (Epac2−/−, open bars) mice. *, P < 0.05 vs. basal [Ca2+]i measured in δ-cells without cAMP of the same
genotype; †, P < 0.05 vs. basal [Ca2+]i measured in Epac2+/+ δ-cells infused with 100 µM cAMP. (B) Summary of IRP determined in Epac2+/+ (filled bars) and
Epac2−/− (open bars) δ-cells with treatments as indicated below. *, P < 0.05 vs. IRP measured in δ-cells without cAMP of the same genotype; †, P < 0.05 vs. IRP
measured in Epac2+/+ δ-cells infused with 100 µM cAMP. (C and D) Somatostatin secretion measured in islets from Epac2+/+ (C, filled bars) and Epac2−/− mice
(D, open bars) under the indicated experimental conditions. *, P < 0.05 vs. 1 mM glucose alone of the same genotype; †, P < 0.05 vs. tolbutamide alone of the
same genotype; ‡, P < 0.05 vs. responses under the same condition in Epac2+/+ islets. In A–D, data are presented as mean values ± SEM of indicated numbers of
independent experiments (n) from two to six animals for each experimental condition. In A and B, experiments were conducted using the standard whole-cell
technique.
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Finally, consistent with the data in Fig. 7 E, elevating intra-
cellular cAMP level with a high concentration of forskolin
(10 µM) exerted a glucose-like effect on δ-cell [Ca2+]i, an effect
that did not correlate with membrane depolarization and AP
firing (Fig. 14 A). Like the spontaneous glucose-induced [Ca2+]i
spikes in hyperpolarized δ-cells (Fig. 13 A), the [Ca2+]i spikes
evoked by forskolin were sensitive to thapsigargin (Fig. 14 B).
Discussion
The central role of somatostatin as a key regulator of pancreatic
islet function is becoming increasingly evident (Zhang et al.,
2014a; van der Meulen et al., 2015; Li et al., 2017, 2018). Soma-
tostatin is a powerful intra-islet inhibitor of insulin and gluca-
gon secretion. Somatostatin receptor antagonists could restore
counterregulatory glucagon secretion at low glucose in diabetic
rats but not in healthy rats, suggesting an increased intra-islet
somatostatin paracrine tone in diabetes (Yue et al., 2012).
Studies on the normal regulation of somatostatin secretion may
help to understand how it becomes perturbed in diabetes.
However, the exact mechanisms regulating somatostatin se-
cretion remain largely unknown (Rorsman and Huising, 2018).
This is mainly due to the scarcity of δ-cells (Brissova et al.,
2005), making it difficult to perform quantitative measure-
ments. Recently, it has become possible to generate transgenic
mice in which fluorescent proteins are specifically expressed in
the δ-cells (e.g., SST-tdRFP and SST-GCaMP3 mice). Access to
these models allows more detailed analysis of δ-cells gene
expression and function (including the mechanisms that control
somatostatin release; Chera et al., 2014; van der Meulen et al.,
2015; Adriaenssens et al., 2016; DiGruccio et al., 2016). Here we
have studied somatostatin secretion, δ-cell electrophysiology,
and intracellular Ca2+ dynamics using intact mouse pancreatic
islets. We demonstrate that glucose stimulates somatostatin
secretion from pancreatic δ-cells through both membrane
potential–dependent (“Vm-dependent”) and –independent (“Vm-
independent”) pathways.
The Vm-dependent and -independent pathways of glucose-
induced somatostatin secretion and their interrelationship are
summarized in Fig. 15.
Evidence for Vm-dependent and -independent regulation of
GISS
The Vm-dependent pathway largely resembles that of β-cells
(Rorsman and Ashcroft, 2018) and involves glucose-induced
closure of KATP channels, membrane depolarization, and AP
firing (Go¨pel et al., 2000). Accordingly, the Vm-dependent effect
of glucose can be mimicked by the KATP channel blocker
tolbutamide.
However, membrane depolarization per se is a weak stimulus
for somatostatin secretion. Supraphysiological concentrations of
extracellular K+ and tolbutamide evoke less somatostatin se-
cretion than high glucose alone (Fig. 1, B and C). It could be
argued that the high [K+]o-induced depolarization under-
estimates the contribution of electrical activity because it only
transiently increases [Ca2+]i (Fig. 5 A). However, we found that,
Figure 12. Electrical activity and [Ca2+]i in δ-cells. Poor temporal correlation between δ-cell action potential firing and [Ca2+]i dynamics. (A) Electrical
activity (Vm, middle) and changes in [Ca2+]i (ΔF/F0; bottom) measured simultaneously from an SST-GCaMP3 δ-cell at 1 mM and 10 mM glucose (top). [Ca2+]i
transients temporally correlated to action potentials are highlighted in red (“triggered” events). (B) Segments of the recording in A in the presence of 10 mM
glucose (i) and after its washout (ii) displayed on an expanded time scale. Dotted vertical lines indicate [Ca2+]i spikes that correlated with action potentials.
Representative of four similar independent experiments in four different islets from four mice. (C) Average integrated [Ca2+]i transients (AUC) of triggered (139
events in nine independent experiments) and spontaneous events (241 events in nine independent experiments). (D) Average spike amplitude of [Ca2+]i
transients (pAUC) when islets were superfused with 10 mM glucose (54 events in four independent experiments) and during the washing out of the glucose
stimulus (14 events in four independent experiments). *, P < 0.05 vs. 10 mM glucose. In C and D, data are presented as mean values ± SEM. All experiments
were conducted using perforated patch whole-cell technique.
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although tolbutamide has an effect on δ-cell electrical activity
comparable to that of glucose, it is a much weaker stimulus for
somatostatin secretion than glucose (Fig. 1 A and Table 1). This
suggests that glucose, in addition to the Vm-dependent effect
described above, also exerts a Vm-independent amplifying effect.
The identity of the intracellular signals underlying this ampli-
fication and links to elevation of glucose has not been estab-
lished, but the data presented here implicate cAMP. A role for
cAMP in the Vm-independent effect of glucose is suggested by
the following three observations: (1) glucose increases intracel-
lular cAMP, (2) the adenylyl cyclase activator forskolin and
cAMP analogues mimic the amplifying effect of glucose, and (3)
the glucose-induced amplifying effect is stimulated by GLP-1 and
reduced by inhibitors of the cAMP effectors PKA and Epac2.
cAMP mediates the Vm-independent effect on GISS by
stimulating δ-cell ER Ca2+ release
Given the importance of cAMP in somatostatin secretion, it
is important to consider the mechanism(s) by which glucose
increases δ-cell [cAMP]i. In a clonal β-cell line (INS-1E), glucose-
stimulated cAMP production was attributed to a Ca2+-activated
soluble adenylyl cyclase (adenylyl cyclase 10), which is sensitive
to ATP, Ca2+, and bicarbonate (Ramos et al., 2008). However,
this is unlikely to be the case in δ-cells because the most
abundantly expressed adenylyl cyclase in mouse δ-cells is
adenylyl cyclase 6 (Adriaenssens et al., 2016; DiGruccio et al.,
2016), which is inhibited by Ca2+ (Guillou et al., 1999). We argue
that glucose-stimulated cAMP production in δ-cells is secondary
to glucose metabolism, rather than a Vm-dependent effect, based
on the following two observations: (1) glucose evoked Epac2-
dependent [Ca2+]i oscillations in δ-cells voltage clamped at Vm,
and (2) somatostatin secretion evoked by high [K+]o-triggered
depolarization in the absence of glucose/forskolin is not sensi-
tive to antagonists of PKA or Epac2. Therefore, it is likely that
elevation in ATP, produced by glucose metabolism, increases
substrate availability for cAMP production by adenylyl cyclase
in glucose-stimulated δ-cells, a mechanism that is similar to
what has been described in β-cells (Dyachok et al., 2008).
Figure 13. Glucose-induced [Ca2+]i oscillations in voltage-clamped δ-cells. Glucose induces spontaneous Epac2-dependent but PKA-independent [Ca2+]i
spikes in voltage-clamped δ-cells. (A) Left: Holding current (I; middle) and changes in [Ca2+]i (ΔF/F0; bottom) measured in parallel from an SST-GCaMP3 δ-cell
voltage-clamped at −70 mV in the presence of 1 mM or 20 mM glucose as indicated (top). Right: Bar graph of the AUCs of [Ca2+]i at 1 and 20 mM glucose as
indicated. Data are presented as mean values ± SEM for six independent experiments with totals of 6 and 34 events at 1 mM and 20 mM glucose, respectively.
*, P < 0.05 vs. 1 mM glucose. (B–D) as in A, but experiments were conducted in islets pretreated with 10 µM thapsigargin (B; three independent experiments
with 2 and 17 events at 1 mM and 20 mM glucose, respectively), 25 µM ESI-05 (C; three independent experiments with 8 and 17 events at 1 mM and 20 mM
glucose, respectively), or 1 µM myr-PKI (D, four independent experiments with 5 and 20 events at 1 mM and 20 mM glucose, respectively). All experiments
were conducted using perforated patch whole-cell technique.
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Indeed, the amplifying effect of glucose is reduced by the glu-
cokinase inhibitor mannoheptulose (Fig. 6, A and B; Zhang et al.,
2007).
Is the glucose-induced increase in cAMP sufficient to explain
the amplifying effect of glucose on somatostatin secretion in
δ-cells? Islets exposed to 10 mM glucose produced ∼3 fmol/islet
cAMP (Fig. 2 D), similar to what was reported previously by
others (Hellman et al., 1974; Eddlestone et al., 1985; Lambillotte
et al., 1997; Kimple et al., 2008; Mourad et al., 2012). Given that
the intracellular volume of a mouse islet is 1.75 nl (Cooper et al.,
1973) and assuming that glucose increases cAMP uniformly in β-
and δ-cells (which together comprise 80–85% of the islet cells;
Brissova et al., 2002, 2005), we estimate that glucose elevates
the intracellular cAMP concentration to ∼2 µM in δ-cells. The
latter assumption seems justified given that the optical cAMP
measurements showed that the responses in δ- and non–δ-cells
were almost superimposable. It has been reported that glucose
suppresses cAMP production in α-cells (Elliott et al., 2015; Yu
et al., 2019; but see Tian et al., 2011). However, given their low
number in the islets (15–20% of the islet cells), the contribution
of α-cells in total islet cAMP production is relatively small, and
the noise introduced into the above estimate should be insig-
nificant. This estimate is close to that producing the half-
maximal increase in δ-cell [Ca2+]i and exocytosis (3 µM; Fig. 7,
C and D). It is also possible that glucose-stimulated cAMP pro-
duction in δ-cells is compartmentalized and the local concen-
tration of the second messenger is underestimated. Such
localized increases in cytoplasmic cAMP have been reported in
neurons (Averaimo et al., 2016) and in ventricular myocytes
(Surdo et al., 2017).
How does cAMP mediate the Vm-independent effect on so-
matostatin secretion? Accumulating evidence indicates that Ca2+
release from the ER represents a key signal for somatostatin
secretion (Zhang et al., 2007; Li et al., 2017; Vierra et al., 2018).
The cAMP-mediated amplifying effect of glucose on somato-
statin secretion is likely to be exerted, at least partially, by
augmenting ER Ca2+ release in δ-cells. This is supported by the
observations that (1) blocking cAMP effectors (PKA/Epac2) with
PKI/ESI-05 and inhibiting ER Ca2+ release (with ryanodine) in-
hibited GISS; and (2) increasing [cAMP]i with forskolin signifi-
cantly enhanced depolarization-triggered [Ca2+]i and exocytotic
response. This also correlated with the occurrence of sponta-
neous [Ca2+]i spikes, which were induced in voltage-clamped
δ-cells by high glucose (20 mM) or forskolin in perforated
patch whole-cell measurements (Figs. 7 E, 13 A, and 14) or in-
tracellular application of cAMP (≥10 µM) or the Epac2 agonist
29-O-Me-cAMP in standard whole-cell recordings (Figs. 8 and
10). The observation that these spikes, in addition to being
maintained in voltage-clamped cells, were abolished by thapsi-
gargin suggests they reflect mobilization of intracellular Ca2+
release from the ER. These spontaneous [Ca2+]i spikes may ac-
count for the paradox that GISS was not inhibited by pharma-
cological membrane hyperpolarization by the KATP channel
activator diazoxide in some studies (Zhang et al., 2007; but see
van der Meulen et al., 2015). The forskolin-induced [Ca2+]i os-
cillations may account for the capacity of high concentrations of
forskolin (10 µM) to stimulate somatostatin secretion at 1 mM
glucose (De Marinis et al., 2010), an effect that was not associ-
ated with δ-cell electrical activity (Fig. 14 A). It may be specu-
lated that the PKA- and Epac2-dependent pathways mediate the
stimulatory effects of other cAMP-elevating factors such as GLP-
1 (Fig. 3 D), ghrelin (Adriaenssens et al., 2016; DiGruccio et al.,
2016) and urocortin 3 (van der Meulen et al., 2015) on somato-
statin secretion.
Figure 14. Forskolin-induced [Ca2+]i oscillations without δ-cell electrical activity. Forskolin induces spontaneous [Ca2+]i spikes sensitive to thapsigargin.
(A)Membrane potential (Vm, middle) and changes in [Ca2+]i (ΔF/F0; bottom) measured simultaneously from an SST-GCaMP3 δ-cell in the absence and presence
of 10 µM forskolin. Representative of five independent experiments from three animals. Addition of forskolin is indicted by the horizontal bar. (B) As in A, but in
δ-cells pretreated with thapsigargin (10 µM) for >1 h. Representative of three independent experiments from three animals. All experiments were conducted
using the perforated patch whole-cell technique.
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Differential roles of PKA and Epac2 in GISS
Importantly, although the effects of inhibiting PKA (using PKI)
and Epac2 (using ESI-05) on GISS were similar and nonadditive
(Figs. 3 and 4), themore detailed single-cell analyses suggest that
they are not identical. Thus, PKI (unlike ESI-05) did not affect
the cAMP-induced increase in [Ca2+]i in voltage-clamped δ-cells.
This suggests that there is a hierarchy of the PKA- and Epac2-
mediated effects: Epac2 is tightly linked to intracellular Ca2+
release, whereas PKAmay act at the level of exocytosis by effects
similar to those documented in pancreatic α- (Gromada et al.,
1997) and β-cells (Amma¨la¨ et al., 1993). The concept that Epac2 is
linked to Ca2+ release is supported by the observation that ac-
tivating Epac2 alone was sufficient to trigger spontaneous [Ca2+]i
oscillations and elevate basal [Ca2+]i in δ-cells (Fig. 10, B and E).
It is therefore of interest that Epac2 has been reported to in-
crease the opening probability of intracellular Ca2+-releasing
RYR channel in INS-1 cells (Kang et al., 2001) and car-
diomyocytes (Pereira et al., 2007). The latter effect on car-
diomyocytes has been attributed to activation of CaMK II, which
is downstream of the activation of phospholipase Cε (PLCε) and
PKC (Oestreich et al., 2009). However, it should be noted that
PLCε (Plce1) is expressed at very low levels (if at all) in δ-cells
(DiGruccio et al., 2016). This cAMP-induced increase in RYRs
activity in δ-cells may constitute the increase in basal [Ca2+]i
(Fig. 7). Notably, a moderate increase in basal [Ca2+]i from ∼100
to 240 nM (below the threshold for triggering exocytosis) re-
sulted in an ∼80% increase in depolarization-evoked exocytosis
(Fig. 9). We attribute this effect to increased Ca2+-dependent
granule priming (Heinemann et al., 1993; Gromada et al., 1999).
Will the increased basal [Ca2+]i also promote CICR through
higher ER store-filling? Comparing with the cAMP infusion
experiments (Fig. 7), increasing basal [Ca2+]i without cAMP
had a relatively small effect on enhancing the depolarization-
triggered exocytosis without promoting post-depolarization se-
cretion (Fig. 9, A and B). This indicates an increase in basal
[Ca2+]i per se is insufficient in promoting CICR. Indeed,
depolarization-triggered [Ca2+]i transients were not signifi-
cantly affected by acutely elevated basal [Ca2+]i (Fig. 9, C and D).
In addition, it appears that cAMP can stimulate exocytosis
directly by activation of PKA, as suggested by the strong in-
hibitory effect of PKA blockers on both exocytosis (Fig. 10, A and
C) and somatostatin secretion (Fig. 4), even when intracellular
Ca2+ activity was stimulated (via Epac2 activation). Although
PKA has been reported to phosphorylate RYR3 (the RYR ex-
pressed in δ-cells; Zhang et al., 2007) and increase its channel
activity (Ooashi et al., 2005), it appears that such an effect is less
important in δ-cells as PKI did not affect intracellular Ca2+ re-
lease (Fig. 10 F and Fig. 13 D) or the increase in basal [Ca2+]i
(Fig. 10 B). This hypothesis is further supported by the effects of
genetic ablation of Epac2: in Epac2-deficient δ-cells, cAMP failed
Figure 15. Glucose stimulates somatostatin secretion through both membrane potential-dependent and -independent pathways. Membrane po-
tential (Vm)–dependent pathway: glucose (large red particles) metabolism increases δ-cell intracellular ATP (green particles) at the expense of ADP and
consequently inhibits the KATP channels (sensitive to tolbutamide). This leads to membrane depolarization and increase in electrical activity that opens voltage-
gated Ca2+ channels (VGCC) to allow influx of extracellular Ca2+ (blue particles) to increase [Ca2+]i. This exerts a relatively weak stimulation on δ-cell exocytosis
(dotted line). Vm-independent pathway: high glucose stimulates somatostatin secretion by promoting CICR in δ-cells. First, the glucose-induced stimulation of
ATP production increases ER luminal Ca2+ content through SERCA pump. Second, glucose metabolism elevates [cAMP]i (dark blue particles), a second
messenger which activates PKA and Epac2. Whereas PKA directly potentiates δ-cell exocytosis, the effect of Epac2 on exocytosis is mediated through the
activation of RYR3 and sensitization of CICR. The cAMP-dependent effects are mimicked by the adenylyl cyclase activator forskolin. The Vm-dependent and
-independent pathways operate synergistically leading to a full stimulatory effect of somatostatin secretion by glucose. The key events (increase in ATP/ADP
ratio, KATP channel closure, action potential firing, increase in [cAMP]i, CICR, increase in [Ca2+]i, and exocytosis) are highlighted in pink boxes. Green arrows
indicate stimulation, and the red blind-ended arrows indicate inhibition. sER, smooth endoplasmic reticulum; GLUT, glucose transporter.
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to increase [Ca2+]i and stimulate exocytosis, while GISS was
abolished by the PKA inhibitor Rp-8-Br-cAMPS (Fig. 11).
cAMP-independent effects on Vm-independent GISS
The finding that cAMP mediates part of the Vm-independent
effect of glucose does not exclude the contribution of other
mechanisms. It is noteworthy that whereas the forskolin stim-
ulatory effect on depolarization-evoked somatostatin secretion
was nearly abolished by PKI and ESI-05, part of the effect of
glucose was resistant to these inhibitors (Fig. 4, A and B). It is
possible that glucose mediates this effect by promoting Ca2+
uptake into the intracellular Ca2+ stores (Fig. 6, C and D). Thus,
the increase in δ-cell exocytosis at high glucose correlates with
the high level of Ca2+ available for release from the ER (Fig. 6, E
and F). This may also explain the observation that blocking the
RYR or the R-type Ca2+ channel (the two key components for
δ-cell CICR) had no inhibitory effect on high [K+]o-triggered
somatostatin secretion in the absence of glucose (Zhang et al.,
2007).
Full magnitude GISS requires both Vm-dependent and
-independent pathways
How do the Vm-dependent and -independent pathways con-
tribute to GISS? When intracellular cAMP is low (at low glu-
cose), isolated opening of R-type Ca2+ channels is insufficient to
trigger CICR and the full secretory response. This accounts for
the low amplitude of the depolarization-evoked [Ca2+] transients
in the absence of cAMP (Fig. 7 and Table 2) and by the reported
lack of effect of the R-type Ca2+ channel blocker SNX-482 on
high [K+]o-stimulated somatostatin secretion in the absence of
glucose (Zhang et al., 2007). On the other hand, without mem-
brane depolarization/activation of voltage-gated Ca2+ channels,
elevating intracellular cAMP (with forskolin) alone had only a
weak stimulatory effect on somatostatin secretion (De Marinis
et al., 2010), despite the increase in spontaneous ER Ca2+ release
(Fig. 14 A). Therefore, the synergistic effects of membrane de-
polarization, opening of R-type Ca2+ channels and cAMP-
dependent ER Ca2+ release are required for glucose to exert its
full stimulatory effect on somatostatin secretion.
Coda
It is clear that the regulation of hormone secretion from δ- and
β-cells exhibits many similarities. Both processes involve Vm-
dependent and -independent mechanisms. In insulin-secreting
cells, GLP-1 has been shown to induce CICR by a cAMP-
dependent mechanism (Gromada et al., 1995; Dzhura et al.,
2010). However, the two types of islet cells do differ in several
important respects. Whereas modulators of CICR do not affect
glucose-induced insulin secretion from mouse β-cells, CICR
plays a central role in glucose-stimulated somatostatin secretion
from δ-cells (Zhang et al., 2007). This study identifies cAMP and
activation of Epac2 as a critical link between glucose metabolism
and δ-cell CICR. This explains the observation that the δ-cell
electrical activity appears to play a less decisive role in soma-
tostatin secretion and that the Vm-independent pathways can
maintain somatostatin secretion even in the absence of regen-
erative electrical activity. Unlike β- and α-cells, which exhibit
spherical geometry, the δ-cells are more complex. In addition to
a cell body, they also possess neurite-like processes that may
extend several tens of microns and thereby attain close prox-
imity to several β- or α-cells (Brereton et al., 2015). Future
studies with improved genetically encoded Ca2+ indicators (such
as GCaMP6)may enable the resolution of Vm-independent [Ca2+]i
spikes in these processes, and whether they represent a means
by which δ-cells can respond to factors released locally by α- and
β-cells and adjust somatostatin secretion accordingly.
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